| | | 深圳瑞华泰薄膜科技股份有限公司 关于"瑞科转债"预计满足转股价格修正条件 的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、可转债发行上市概况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意深圳瑞华 泰薄膜科技股份有限公司向不特定对象发行可转换公司债券注册的批复》（证监 许可〔2022〕1546 号）同意注册，深圳瑞华泰薄膜科技股份有限公司（以下简 称"公司"）于 2022 年 8 月 18 日向不特定对象共计发行 430 万张可转换公司债 券（以下简称"可转债"），每张面值为人民币 100 元，按面值发行，本次发行总 额为人民币 43,000.00 万元，可转债期限为自发行之日起六年。 经上海证券交易所（以下简称"上交所"）自律监管决定书[2022]251 号文 同意，公司 43,000.00 万元可转债于 2022 年 9 月 14 日起在上交所挂牌交易，债 券简称"瑞科转债"，债券代码"118018"。 根据相关规定及《深圳瑞华泰薄膜科技股份有限公司 2022 年度向不特定对 ...

深圳瑞华泰薄膜科技股份有限公司 2025 年第二次临时股东会 会议资料 股票代码：688323 股票简称：瑞华泰 转债代码：118018 转债简称：瑞科转债 二〇二五年十一月 深圳瑞华泰薄膜科技股份有限公司 2025 年第二次临时股东会会议资料 深圳瑞华泰薄膜科技股份有限公司 2025 年第二次临时股东会会议资料 目录 | 2025 | 年第二次临时股东会会议须知…………………………………………..…… | 2 | | --- | --- | --- | | 2025 | 年第二次临时股东会会议议程………………………………………..……… | 4 | | | 议案一：关于为全资子公司提供担保的议案……………………………….….…..6 | | 1 深圳瑞华泰薄膜科技股份有限公司 2025 年第二次临时股东会会议资料 三、会议按照会议通知上所列顺序审议、表决议案。 四、股东及股东代理人参加股东会依法享有发言权、质询权、表决权等权利。 股东及股东代理人参加股东会应认真履行其法定义务，不得侵犯公司和其他股东 及股东代理人的合法权益，不得扰乱股东会的正常秩序。 五、现场要求提问的股东及股东代理人，应当按照会议的议程举 ...

Shareholder Reduction Plans - Zhongjing Technology's shareholder Longi Green Energy plans to reduce holdings by no more than 3.8764 million shares [1] - Guobo Electronics' shareholder China Electronics Technology Group plans to reduce holdings by no more than 2.00% [1] - Hongbai New Materials' shareholder Xinyu Baolong plans to reduce holdings by no more than 19.5 million shares [1] - Founder Securities' shareholder China Cinda plans to reduce holdings by no more than 82.321 million shares [1] - Ningbo Zhongbai's shareholder Zhang Jiangbo plans to reduce holdings by no more than 1% [1] - Suli Co., Ltd.'s shareholder Gusheng Investment plans to reduce holdings by no more than 900,000 shares [1] - Ruihua Tai's shareholder Hangke New Century plans to reduce holdings by no more than 180,000 shares [1] - Shenkong's shareholder More Liangzhao plans to reduce holdings by no more than 2% [1] Other Notable Events - Yao Yigou received a tax matter notification [1] - ST Lingnan is being prosecuted for alleged collusion in bidding [1]

Group 1 - Shareholders of Hongbo New Materials plan to reduce their holdings by no more than 3% of the company's shares [1] - Shareholders of Ruihua Tai plan to reduce their holdings by no more than 1% of the company's shares [1] - Trina Solar has signed a memorandum of cooperation with Pacific Green for a 5GWh grid-level battery energy storage system [1] Group 2 - The subscription for Zhuomei Convertible Bonds will open on November 7 [1] - Dapeng Industrial is a new stock available for subscription on the Beijing Stock Exchange [1] Group 3 - The table provides details on various convertible bonds, including their redemption prices, current prices, last trading dates, and conversion values [2][4]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688323 证券简称：瑞华泰公告编号：2025-047 转债代码：118018 转债简称：瑞科转债 深圳瑞华泰薄膜科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 大股东持有的基本情况 ● 减持计划的主要内容 航科新世纪拟通过集中竞价方式减持数量合计不超过1,800,002股（不超过公司总股本比例1.0000%）。 本次减持计划自本公告披露之日起15个交易日之后的3个月内实施。 上述股份减持价格按市场价格确定，若减持期间公司有派息、送股、资本公积金转增股本、配股等除权 除息事项，减持计划将进行相应调整。 公司于近日收到股东航科新世纪出具的《关于股份减持计划的告知函》，现将相关减持计划公告如下： 一、减持主体的基本情况 ■ 上述减持主体无一致行动人。 截至本公告披露日，航科新世纪科技发展（深圳）有限公司（以下简称"航科新世纪"）持有深圳瑞华泰 薄膜科技股份有限公司（以下简称"公司"） 42,083 ...

Group 1 - The core viewpoint of the article highlights the exceptional properties of polyimide, particularly its excellent radiation resistance, which allows it to maintain long-term reliability in high radiation and extreme environments [2] - Polyimide is recognized as the best polymer material for high and low-temperature insulation, playing a crucial role in insulation systems within special and complex environments [2]

Core Insights - On November 4, six A-share listed companies disclosed share buybacks, including Huakai Yibai, Midea Group, and Ningde Times [1] - Seventeen A-share listed companies announced share reductions, including Yinghe Technology and Tianhe Solar [1] Buyback Summary - Huakai Yibai: Director Zhuang Junchao plans to buy back at least 30 million yuan worth of shares [2] - Midea Group: Has repurchased A-shares totaling 9.575 billion yuan [2] - Qingyue Technology: Actual controller Gao Yudi proposed a buyback of 10 million to 20 million yuan [2] - Shenzhen Ruijie: Obtained a commitment letter for a special loan for stock buyback [2] - Ningde Times: As of October 31, has repurchased 15.9908 million shares for a total amount of 4.386 billion yuan [2] - Huarong Co.: Plans to buy back shares worth 40 million to 125 million yuan [2] Reduction Summary - Yinghe Technology: Director Wang Jun plans to reduce holdings by no more than 2,700 shares [2] - Shenzhou Information: Shareholder Shen Chang Technology has completed the reduction of 9.5 million shares [2] - Tianhe Solar: Youze Venture Capital reduced holdings by 12.4749 million shares from September 5 to November 3 [2] - Hongbai New Materials: Shareholder Xinyu Baolong plans to reduce no more than 3% of shares [2] - Guobo Electronics: Shareholder Zhongdian Ke Guomi plans to reduce no more than 2% of shares [2] - Aorite: Shareholder Tiantai Boren plans to reduce no more than 0.25% of shares [2] - Yinuosi: Shareholder Zhangjiang Biomedical Base plans to transfer 4.2294 million shares, accounting for 3% of total equity [2] - Founder Securities: Third-largest shareholder China Cinda plans to reduce no more than 1% of shares [2] - Nine Company: Depository receipt holders plan to reduce no more than 0.04% of depository receipts [2] - Ningbo Zhongbai: Shareholder Zhang Jiangbo plans to reduce no more than 1% of shares [2] - Fudan Zhangjiang: Shareholder Yang Zongmeng plans to reduce no more than 1% of shares [2] - Liqun Co.: Director and executive Hu Peifeng plans to reduce no more than 0.08% of shares [2] - Suli Co.: Shareholder Jiesheng Investment plans to reduce no more than 0.48% of shares [2] - Shengkong Co.: Shareholder More Light plans to reduce no more than 2% of shares [2] - Ruihua Tai: Shareholder Hangke New Century plans to reduce no more than 1% of shares [2] - Shentong Technology: Directors Wang Huan and Zhou Baocong plan to reduce no more than 0.0473% of shares [2] - Huapei Niuwu: Shareholder Guoshou Chengda plans to reduce no more than 2% of shares [2]

Summary of Key Points Core Viewpoint - Several shareholders across various companies are planning to reduce their stakes, indicating potential shifts in ownership dynamics within the market [1]. Group 1: Shareholder Reductions - Hongbo New Materials' shareholder, Xinyu Baolong, intends to reduce its stake by 3% [1]. - Dayilong's shareholder, Lefeng Investment, has reduced its stake by 3% [1]. - Ningbo Zhongbai's Zhang Jiangbo plans to reduce his stake by 1% [1]. - Founder Securities reports that China Cinda plans to reduce its stake by 1% within three months [1]. - Liqun Co., Ltd.'s director, Hu Peifeng, intends to reduce his stake by 0.08% [1]. - Suli Co., Ltd.'s Guosheng Investment plans to reduce its stake by 0.4816% [1]. - Jinzhen Co., Ltd.'s Zhao Jian and Xu Minbo have reduced their stakes by 0.98% and 0.11%, respectively [1]. - Shenkong Technology's Wang Huan and Zhou Baocong plan to reduce their stakes by up to 0.0263% and 0.0210% within three months [1]. - Huaxi Biological's shareholder, Guoshou Chengda, plans to reduce its stake by no more than 2% [1]. - Xuanta Pharmaceutical's Qihe Venture has reduced its stake by 0.7098% [1]. - Desheng Technology's actual controller, Guo Xiaobin, has reduced his stake by 0.51% [1]. - Liren Technology's Liren Investment has reduced its stake by 0.0779% [1]. Group 2: Shareholder Increases - Zhongju Gaoxin's Li Ruxiong has increased his stake by 0.0129% [1].

Group 1 - Jilin Chemical Fiber's controlling shareholder, Jilin Chemical Fiber Group, completed a capital increase and share expansion, raising registered capital from 809 million to 2.508 billion yuan, with the State-owned Assets Supervision and Administration Commission's shareholding increasing to 67.09% [2] - Lepu Medical's subsidiary received NMPA registration approval for a rechargeable implantable deep brain stimulation system, aimed at assisting patients with advanced Parkinson's disease [3] - Zhenai Home announced a potential change in control, leading to a stock suspension starting November 5, 2025, due to ongoing negotiations [4] Group 2 - Yutong Bus reported a 5.62% year-on-year decline in October sales, with total sales for the year increasing by 5.87% [11] - Qianli Technology's October sales surged by 111.44%, with significant growth in both new energy and other vehicle categories [12] - Sike Xide's major shareholder completed a reduction of 825,195 shares, raising a total of approximately 22.84 million yuan [14] Group 3 - Far East Holdings' subsidiary secured contracts exceeding 1 billion yuan in October, which is expected to positively impact future performance [24] - Quan Yang Quan's subsidiary won a 1.48 billion yuan project for airline drinking water supply, anticipated to enhance future earnings [25] - Guoji Automobile's subsidiary won an 8.09 billion yuan project for a lightweight component factory, expected to positively influence operational performance [26]

Group 1 - Jinguang Electric won a bid for a State Grid procurement project with a total amount of 21.7976 million yuan, accounting for approximately 2.93% of the company's expected revenue for 2024 [1] - Shen Gong Co. plans to reduce its shareholding by up to 2%, equating to 340.61 million shares [2] - Guomai Culture received a government subsidy of 3.78 million yuan, representing 24.90% of its audited net profit for 2024 [2] Group 2 - Guomai Culture focuses on the development and provision of digital content operation platforms [3] - Shentong Technology's two directors plan to collectively reduce their shareholding by no more than 0.0473% [4] - Ruihua Tai intends to reduce its shareholding by up to 1%, amounting to 1.8 million shares [5] Group 3 - Guoji Automobile's wholly-owned subsidiary won a total contract project worth 809 million yuan [7] - Changcheng Technology's stock is expected to remain suspended due to potential changes in control [9] - Huabei Pharmaceutical's subsidiary received approval for a chemical raw material drug listing application [11] Group 4 - Fuyao Glass has changed its legal representative to Cao Hui [13] - Huaxi Biological plans to reduce its shareholding by up to 2%, totaling 9.6336 million shares [14] - Hopu Co. signed a procurement contract for a storage system worth 500 million yuan [15] Group 5 - ST Songfa's subsidiary plans to invest 458 million yuan in a mooring dock project [18] - Zhonghong Medical's subsidiary is expected to be selected for several centralized procurement projects [19] - Huakai Yibai's vice chairman plans to increase his shareholding by no less than 30 million yuan [20] Group 6 - Haichuang Pharmaceutical completed the first participant enrollment for a clinical trial of a drug for metabolic-associated fatty liver disease [21] - Dongfang Biological's subsidiary obtained medical device product registration certificates for multiple products [22] - Lepu Medical's rechargeable implantable deep brain stimulation system received NMPA registration approval [23] Group 7 - Changyuan Power's power generation in October decreased by 32.25% year-on-year [24] - Jinshi Yaya's diclofenac sodium sustained-release tablets passed the consistency evaluation for generic drugs [26] - Yutong Bus sold 3,040 buses in October, a decrease of 5.62% year-on-year [27] Group 8 - Far East Co. signed contracts worth 1.062 billion yuan in October [28] - Tianya Pharmaceutical's subsidiary passed the consistency evaluation for a drug [29] - Yuheng Pharmaceutical plans to resolve a debt dispute through a share transfer agreement [30] Group 9 - Hailanxin's subsidiary won a bid for a marine observation network project worth 1.097 billion yuan [31] - Huasheng Lithium plans to reduce its shareholding by up to 0.37% [33] - Maike Biological obtained product registration certificates for five new in vitro diagnostic products [34] Group 10 - Huayuan New Materials signed a strategic cooperation agreement with Taiblue New Energy [37] - Greebo's actual controller and some directors plan to collectively increase their shareholding by no less than 11.5 million yuan [39] - Yian Technology received a government subsidy of 1.1643 million yuan [41] Group 11 - Kangtai Biological's quadrivalent influenza virus vaccine has commenced Phase I clinical trials [43] - Spring Airlines received a commitment letter for a stock repurchase loan of up to 450 million yuan [45] - Foton Motor sold 8,006 new energy vehicles in October, a year-on-year increase of 98.83% [46] Group 12 - Greebo plans to transfer 100% equity of its subsidiary for 280 million yuan [48] - Siwei Liekong's director is under investigation [49] - Dingyang Technology launched a new generation of multi-channel microwave signal generator products [50] Group 13 - Jiangling Motors reported a year-on-year increase of 8.06% in vehicle sales for October [51] - Shengyi Technology plans to reduce its shareholding by up to 1.03% [52] - Dongshan Precision completed the acquisition of 100% equity of France's GMD Group for approximately 814 million yuan [53] Group 14 - Tianyang Technology plans to acquire 7.5% of Baoland's shares for 155 million yuan [54] - Alter plans to establish a joint venture company with a total investment of 672 million yuan [54] - Changchun High-tech's clinical trial application for a drug was approved [55] Group 15 - Beibu Gulf Port's cargo throughput in October increased by 22.73% year-on-year [56] - ST Zhangjiajie was ruled by the court to undergo reorganization [57] - Teda Co.'s subsidiary was selected as a supplier for an energy project in Indonesia [58]